Literature DB >> 15135509

Both ApxI and ApxII of Actinobacillus pleuropneumoniae serotype 1 are necessary for full virulence.

Bouke K H L Boekema1, Elbarte M Kamp, Mari A Smits, Hilde E Smith, Norbert Stockhofe-Zurwieden.   

Abstract

Most serotypes of A. pleuropneumoniae produce more than one toxin in vivo. To determine the value of the production of more than one toxin in the development of disease, we tested the pathogenicity of isogenic strains of A. pleuropneumoniae serotype 1 that are mutated in the toxin genes apxIA and/or apxIIA or in the transport genes apxIBD. Bacteria mutated in both apxIA and apxIIA, or in apxIBD, were unable to induce pathological lesions, thereby confirming the conclusion that ApxI and ApxII are essential for the pathogenesis of pleuropneumonia. Infection with isogenic strains lacking either ApxI or ApxII did not consistently lead to pleuropneumonia unlike the parent strain S4074. ApxII seemed at least as important as ApxI for the development of clinical and pathological symptoms. Only one of the four pigs inoculated with a mutant strain unable to produce ApxII developed mild pneumonia whereas two out of the three pigs inoculated with a mutant strain unable to produce ApxI developed more severe lesions. The results indicate that both ApxI and ApxII of A. pleuropneumoniae serotype 1 are necessary for full virulence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15135509     DOI: 10.1016/j.vetmic.2003.09.024

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  4 in total

1.  Regulation of type IV fimbrial biogenesis in Dichelobacter nodosus.

Authors:  Dane Parker; Ruth M Kennan; Garry S Myers; Ian T Paulsen; J Glenn Songer; Julian I Rood
Journal:  J Bacteriol       Date:  2006-07       Impact factor: 3.490

2.  Predicting genetic traits and epitope analysis of apxIVA in Actinobacillus pleuropneumoniae.

Authors:  Min-Kyoung Shin; Seung-Bin Cha; Won-Jung Lee; Han Sang Yoo
Journal:  J Microbiol       Date:  2011-06-30       Impact factor: 3.422

3.  Enhancement of protective immune responses by oral vaccination with Saccharomyces cerevisiae expressing recombinant Actinobacillus pleuropneumoniae ApxIA or ApxIIA in mice.

Authors:  Sung Jae Shin; Seung Won Shin; Mi Lan Kang; Deog Yong Lee; Moon-Sik Yang; Yong-Suk Jang; Han Sang Yoo
Journal:  J Vet Sci       Date:  2007-12       Impact factor: 1.672

Review 4.  RTX Toxins of Animal Pathogens and Their Role as Antigens in Vaccines and Diagnostics.

Authors:  Joachim Frey
Journal:  Toxins (Basel)       Date:  2019-12-10       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.